Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Breast Cancer – Unmet Need – Unmet Need – Advanced or Metastatic HER2-Positive Breast Cancer (US/EU)
In the last decades, markedly improved survival benefit has been achieved in the treatment of advanced or metastatic HER2-positive breast cancer. Effective HER2-targeted drugs such as Herceptin,…
Heart Failure | Reduced Ejection Fraction | Treatment Algorithms: Claims Data Analysis | US | 2023
Drug treatment of chronic heart failure with reduced ejection fraction (HFrEF) is well established, with a wealth of supporting evidence from clinical trials. ACE inhibitors or ARBs, beta blockers…
Heart Failure | Preserved Ejection Fraction | Treatment Algorithms: Claims Data Analysis | US | 2023
Although heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all chronic heart failure cases and understanding of the disease’s pathophysiology has improved…